Review Article

Analyzing Association of the XRCC3 Gene Polymorphism with Ovarian Cancer Risk

Table 3

Distribution of XRCC3 rs861539 genotype among ovarian cancer cases and controls included in the meta-analysis.

First
author
Year Genotypes distribution
(Case source)
Genotypes distribution
(Controls source)
  P-HWE
(Controls)
T2T2 versus T1T1T1T2 versus T1T1 T1T2+T2T2 versus T1T1 T2T2 versus T1T1+T1T2
T1T1T1T2T2T2T1T1T1T2T2T2OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)

Auranen [20]200567676222717121946583Yes0.99 [0.83, 1.18]0.880.99 [0.88, 1.12]0.890.99 [0.88, 1.11]0.870.99 [0.84, 1.17]0.91
Beesley [26]2007291339101288351108Yes0.93 [0.67, 1.27]0.630.96 [0.77, 1.19]0.690.95 [0.77, 1.17]0.620.95 [0.71, 1.27]0.72
Quaye [25]2009545612175784958282Yes0.89 [0.72, 1.11]0.310.92 [0.79, 1.07]0.270.91 [0.79, 1.05]0.210.93 [0.76, 1.14]0.51
Webb [27]2005591656198307375106Yes0.97 [0.74, 1.28]0.830.91 [0.75, 1.10]0.320.92 [0.77, 1.10]0.371.02 [0.79, 1.32]0.87

Total210323697013091363010790.95 [0.85, 1.06]0.370.95 [0.88, 1.03]0.220.95 [0.88, 1.02]0.190.97 [0.88, 1.08]0.63
Test  for 
heterogeneity
Test  for
heterogeneity
Test  for
heterogeneity
Test  for
 heterogeneity